Case Series/Study
A 26-year-old female obese patient presented with traumatic wounds to her left foot and ankle from a motorcycle accident. She was treated with conservative wound management and was given antibiotics for 5 days. On her follow up appointment 10 days later, her treating physician referred her to wound care due to deteriorating wounds, prescribed oral antibiotics, and ordered wound cultures. Her wounds measured 1.2 cm3 (Proximal), 1.2 cm3 (Heel), 0.96 cm3 (Midfoot) and 0.14 cm3 (Distal). After her cultures came back negative, a bioresorbable silver matrix (Microfilm Matrix) was used to manage bioburden and provide a template to support reepithelialization.
Methods:
The patient’s wounds were debrided with sharp debridement, then Microfilm Matrix was applied as the contact dressing once a week for 4 weeks.
Results:
One week after Microfilm Matrix treatment, all four wounds decreased by 40 to 80%. At week 2 one wound was fully healed, and by week 4, three wounds were greater than 93% healed and the last wound is currently 85% healed.
Discussion:
As the main wound healing therapy, Microfilm Matrix was able to jump-start healing in a deteriorating wound and shows promise in accelerating wound closure and getting patients back to their daily activities as fast as possible.
Trademarked Items:
References: 1) Sarah W. Manning, D. A. H., William R. Shillinglaw, Eric Crawford, Gaurav Pranami, Ankit Agarwal, Michael J. Schurr (2020). "Efficacy of a Bioresorbable Matrix in Healing Complex Chronic Wounds: An Open-Label Prospective Pilot Study." Wounds 32(11).
2) Chatelain, R. (2021). "The Efficacy of a Novel Silver-Containing Bioresorbable Microfilm Matrix in At-Risk Surgical Wounds: A Clinical Case Series." Wounds: a Compendium of Clinical Research and Practice 33(10): 245-252.